+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pet Disease Diagnostic Reagent Market by Disease Category (Genetic Disorder, Infectious Disease, Metabolic Disorder), End User (Homecare Testing, Research Institute, Veterinary Diagnostic Lab), Animal Type, Diagnostic Technology, Test Type - Global Forecast 2025-2030- Product Image
Pet Disease Diagnostic Reagent Market by Disease Category (Genetic Disorder, Infectious Disease, Metabolic Disorder), End User (Homecare Testing, Research Institute, Veterinary Diagnostic Lab), Animal Type, Diagnostic Technology, Test Type - Global Forecast 2025-2030- Product Image
New

Pet Disease Diagnostic Reagent Market by Disease Category (Genetic Disorder, Infectious Disease, Metabolic Disorder), End User (Homecare Testing, Research Institute, Veterinary Diagnostic Lab), Animal Type, Diagnostic Technology, Test Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6137563
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The demand for specialized diagnostic reagents designed to detect and monitor a spectrum of pet diseases has never been more critical. As companion animals take on the role of family members and livestock productivity remains vital for food security, researchers and clinicians alike require high-precision tools to deliver accurate disease identification. The complexity of genetic disorders alongside emergent infectious threats underscores the need for reagents that combine sensitivity, specificity, and adaptability across various species. This report brings into focus the core drivers shaping reagent development, from the rise of precision therapeutics to the integration of digital diagnostic platforms that streamline decision making in veterinary and homecare environments.

Drawing upon the latest peer-reviewed studies, regulatory updates, and expert interviews, the analysis captures how stakeholder demands are evolving. By mapping the intersections between technological progress and end-user expectations, this introduction frames the expansive landscape that manufacturers and providers must navigate. With a foundational understanding of market dynamics, readers will be prepared to explore the shifts, challenges, and opportunities that define the contemporary pet disease diagnostic reagent sector.

Unveiling the Technological Innovations and Industry Evolution That Are Reshaping the Pet Disease Diagnostic Reagent Market and Driving New Standards of Care

Transformative Shifts Reshaping the Pet Diagnostic Reagent Arena

Recent years have witnessed a profound acceleration of technological advancements and strategic realignments that are redefining the pet disease diagnostic reagent ecosystem. Next generation sequencing and polymerase chain reaction platforms have transitioned from centralized laboratories to point-of-care settings, enabling veterinarians to obtain molecular-level insights in near real time. Concurrently, the adoption of rapid immunoassays and digital data integration tools has lowered barriers for in-home testing, unlocking new revenue streams while elevating animal welfare through earlier detection and monitoring of chronic conditions.

Parallel to these technological evolutions, industry consolidation and cross-sector partnerships have emerged as critical enablers of growth. Collaborative efforts between diagnostic developers and pharmaceutical or animal health companies are accelerating reagent innovation, particularly for neglected parasitic and genetic disorders. Moreover, the focus on modular reagent design and open-architecture platforms is empowering laboratories and hospitals to customize testing panels around specific epidemiological trends. These transformative shifts collectively underscore the dynamic nature of the market and the imperative for stakeholders to align their strategies with the pace of change.

Examining the Broad Effects of United States Tariffs Introduced in 2025 on the Global Supply Chain and Cost Structures of Pet Disease Diagnostic Reagents

Analyzing the Ripple Effects of New United States Tariff Measures

The introduction of targeted tariff adjustments by the United States in 2025 has exerted multifaceted pressures on the global supply chain for pet disease diagnostic reagents. Key raw materials, often sourced from specialized suppliers in Asia Pacific and Europe, experienced increased import duties that translated into higher manufacturing costs. This cost escalation compelled reagent producers to reevaluate procurement strategies, negotiate alternative supply agreements, and invest in inventory buffering to mitigate disruptions. In response, some manufacturers initiated localized production partnerships to preserve margin stability and ensure uninterrupted access to critical assay components.

Beyond immediate cost implications, the tariffs prompted a strategic shift toward supply chain resilience and diversification. Companies are enhancing end-to-end visibility by adopting advanced analytics to forecast demand fluctuations and potential bottlenecks. At the same time, there has been an accelerated move to consolidate logistics networks and leverage free trade zones to offset duty burdens. These adaptations are fostering a more robust reagent ecosystem-one that balances competitive pricing with the agility required to navigate future policy shifts and maintain seamless diagnostic operations.

Revealing Segmentation Insights That Illuminate How Disease Categories, End Users, Animal Types, Diagnostic Technologies, and Test Types Influence Market Behaviors

In-Depth Segmentation Insights Driving Targeted Growth Strategies

A nuanced understanding of market segmentation reveals how disease categories, end users, animal types, diagnostic technologies, and test types collectively shape demand for reagents. Within disease categories, genetic disorders and oncology assays are gaining traction as veterinarians emphasize early detection and personalized treatment plans. Concurrently, the persistent prevalence of infectious diseases-spanning bacterial, fungal, and viral infections-continues to drive routine screening protocols, while reagents targeting ectoparasitic, helminth, and protozoan infections remain indispensable in livestock and equine health management.

Examining end users uncovers distinct operational imperatives. Homecare testing demands user-friendly formats and rapid turnaround, whereas research institutes prioritize assay robustness and multiplexing capabilities. Veterinary diagnostic laboratories balance throughput and flexibility, and hospitals often require comprehensive reagent portfolios to support 24/7 operations. Species-specific validation further differentiates the market, as cats, dogs, equine, livestock, and poultry each present unique biomarker profiles. Technological considerations-from enzyme-linked immunosorbent assays and immunohistochemistry to next generation sequencing, polymerase chain reaction, and rapid tests-influence sensitivity, throughput, and cost per analysis. Finally, test type segmentation underscores divergent workflows: antibody tests facilitate serological surveillance, antigen assays offer rapid pathogen detection, biochemical tests underpin clinical chemistry panels, and molecular tests-incorporating isothermal amplification, NGS, PCR, and qPCR-cater to high-precision diagnostics and emerging zoonotic threats.

Mapping Regional Nuances in the Americas, Europe Middle East and Africa, and Asia Pacific to Uncover Growth Drivers and Adoption Patterns in Pet Disease Diagnostics

Key Regional Insights Highlighting Distinct Market Dynamics Across Three Major Territories

In the Americas, established veterinary care infrastructures and a robust companion animal treatment culture drive substantial reagent consumption in canine and feline diagnostics. North American adoption of digital pathology and automated immunoassays has accelerated cost efficiencies, while Latin American markets are experiencing growth through expanded livestock health programs and strategic partnerships aimed at parasitic disease control. Regulatory harmonization efforts across trade blocs are streamlining reagent approvals, enabling swifter market entry for innovative assays.

In Europe, Middle East, and Africa, a diverse regulatory landscape coexists with significant investments in research and advanced veterinary education. Western Europe leads in next generation sequencing applications for rare genetic diseases, whereas emerging economies in Eastern Europe and the Middle East focus on infectious disease surveillance. Africa’s livestock sector relies heavily on rapid immunoassays to detect endemic parasitic infections. In Asia Pacific, rapid industrialization and rising disposable incomes are fueling demand for at-home diagnostic solutions and veterinary hospital expansions. China and India, in particular, are emerging as hubs for reagent manufacturing and cross-border collaborations, reinforcing the region’s pivotal role in global supply chains.

Analyzing Leading Industry Players and Emerging Innovators Advancing Novel Pet Disease Diagnostic Reagent Solutions and Strategic Collaborations

Strategic Company Profiles and Competitive Landscape Analysis

Leading global firms and innovative challengers are forging distinct pathways to capture value in the pet disease diagnostic reagent market. Prominent organizations leverage expansive distribution networks and deep research capabilities to develop end-to-end reagent portfolios, encompassing everything from routine immunoassays to advanced molecular diagnostics. By contrast, specialized players focus on niche applications-such as genetic panels for hereditary disorders or high-throughput sequencing kits for zoonotic pathogen surveillance-often securing competitive advantage through rapid product iteration and targeted clinical validations.

Collaborations and strategic alliances further color the competitive terrain. Partnerships between diagnostic developers and pharmaceutical companies are streamlining the co-development of companion diagnostics, while forged alliances with veterinary hospitals and research institutes facilitate real-world performance assessments. Emerging technology providers, backed by venture capital, are introducing novel reagent chemistries and microfluidics platforms, challenging established incumbents to accelerate innovation cycles. Through strategic mergers and geographic expansion initiatives, several companies are reinforcing their footprints in high-growth regions, ensuring comprehensive reagent portfolios align with evolving end-user needs.

Formulating Actionable Strategic Imperatives for Industry Leaders to Strengthen Market Positioning and Accelerate Adoption of Cutting Edge Diagnostic Innovations

Actionable Recommendations for Industry Leaders to Enhance Competitive Positioning

To capitalize on market momentum and navigate ongoing uncertainties, companies should prioritize supply chain diversification and strategic sourcing agreements. Securing alternative reagent raw material suppliers across multiple geographies will mitigate the risk of policy-driven disruptions and safeguard production continuity. Concurrently, investing in modular manufacturing platforms that enable rapid scale-up or format customization will address fluctuating end-user demands and accelerate time-to-market for new assays.

Moreover, forging joint development partnerships with veterinary practitioners and academic centers can unlock co-creation opportunities for novel reagent formulations and diagnostic panels. Organizations should also explore digital health integrations-leveraging cloud connectivity and artificial intelligence analytics-to deliver actionable insights at the point of care. Finally, engaging proactively with regulatory bodies to harmonize approval pathways and establish clear performance standards will streamline market entry for innovative diagnostics and reinforce stakeholder confidence.

Detailing Rigorous Multi Method Research Approach Integrating Qualitative and Quantitative Analyses for Unparalleled Insights in Pet Diagnostics

Research Methodology Underpinning Robust Market Insights

This analysis is founded on a rigorous multi-method research approach that integrates qualitative and quantitative data for comprehensive market understanding. Primary interviews with veterinarians, diagnostic laboratory managers, industry executives, and regulatory experts provided firsthand perspectives on emerging trends and operational challenges. Secondary desk research encompassed peer-reviewed publications, patent filings, and regulatory guidance to validate technological developments and approval timelines.

Quantitative analyses were conducted through data triangulation, combining shipment statistics, procurement records, and supply chain performance metrics to ensure accuracy and reliability. Expert panel discussions and advisory consultations were leveraged to interpret nuanced market dynamics, particularly around segmentation intricacies and regional regulatory nuances. This methodological framework delivers unparalleled clarity on strategic imperatives, competitive positioning, and growth opportunities within the pet disease diagnostic reagent landscape.

Synthesizing Critical Findings and Forward Looking Perspectives to Guide Stakeholders in Advancing Pet Disease Diagnostic Reagent Excellence

Conclusion Synthesizing Critical Findings and Future Outlook

The pet disease diagnostic reagent market stands at the intersection of technological innovation, evolving regulatory frameworks, and expanding end-user expectations. Advanced molecular platforms and rapid immunoassays are broadening diagnostic horizons, while tariff-induced supply chain shifts underscore the need for resilience and strategic agility. Segmentation insights reveal that distinct disease categories, species profiles, and test methodologies demand tailored reagent solutions, and regional variances highlight the importance of adaptive market strategies.

By synthesizing these findings, stakeholders are equipped with a holistic view of where and how to allocate resources, form strategic partnerships, and pursue innovation. The landscape ahead promises continued convergence of digital and biological sciences, presenting opportunities for companies that can rapidly pivot to meet emerging health challenges and regulatory imperatives in pet care.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Disease Category
    • Genetic Disorder
    • Infectious Disease
      • Bacterial Infection
      • Fungal Infection
      • Viral Infection
    • Metabolic Disorder
    • Oncology
    • Parasitic Disease
      • Ectoparasitic Infection
      • Helminth Infection
      • Protozoan Infection
  • End User
    • Homecare Testing
    • Research Institute
    • Veterinary Diagnostic Lab
    • Veterinary Hospital
  • Animal Type
    • Cat
    • Dog
    • Equine
    • Livestock
    • Poultry
  • Diagnostic Technology
    • Enzyme Linked Immunosorbent Assay
    • Immunohistochemistry
    • Next Generation Sequencing
    • Polymerase Chain Reaction
    • Rapid Test
  • Test Type
    • Antibody Test
    • Antigen Test
    • Biochemical Test
    • Molecular Test
      • Isothermal Amplification Test
      • NGS Test
      • PCR Test
      • qPCR Test
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • IDEXX Laboratories, Inc.
  • Zoetis Inc.
  • Thermo Fisher Scientific Inc.
  • Merck & Co., Inc.
  • Heska Corporation
  • Bio-Rad Laboratories, Inc.
  • Neogen Corporation
  • Virbac SA
  • Vetoquinol SA
  • Biogal Galed Laboratories Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of multiplex PCR panels for simultaneous detection of multiple pet pathogens
5.2. Development of CRISPR-Cas based point-of-care assays for rapid canine and feline disease screening
5.3. Rising integration of microfluidic biosensor platforms for in-clinic pet disease diagnostics
5.4. Expansion of companion animal genetic testing panels for hereditary disease risk assessment
5.5. Surge in at-home pet health monitoring kits integrating smartphone-based immunoassays and sensors
5.6. Adoption of AI-driven analytical software for enhanced interpretation of veterinary diagnostic reagent results
5.7. Heightened focus on zoonotic pathogen surveillance in companion animals using rapid serological reagents
5.8. Regulatory harmonization initiatives enabling faster approval of novel veterinary diagnostic reagents in key markets
5.9. Emergence of isothermal amplification methods for rapid in-clinic detection of pet viral infections
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pet Disease Diagnostic Reagent Market, by Disease Category
8.1. Introduction
8.2. Genetic Disorder
8.3. Infectious Disease
8.3.1. Bacterial Infection
8.3.2. Fungal Infection
8.3.3. Viral Infection
8.4. Metabolic Disorder
8.5. Oncology
8.6. Parasitic Disease
8.6.1. Ectoparasitic Infection
8.6.2. Helminth Infection
8.6.3. Protozoan Infection
9. Pet Disease Diagnostic Reagent Market, by End User
9.1. Introduction
9.2. Homecare Testing
9.3. Research Institute
9.4. Veterinary Diagnostic Lab
9.5. Veterinary Hospital
10. Pet Disease Diagnostic Reagent Market, by Animal Type
10.1. Introduction
10.2. Cat
10.3. Dog
10.4. Equine
10.5. Livestock
10.6. Poultry
11. Pet Disease Diagnostic Reagent Market, by Diagnostic Technology
11.1. Introduction
11.2. Enzyme Linked Immunosorbent Assay
11.3. Immunohistochemistry
11.4. Next Generation Sequencing
11.5. Polymerase Chain Reaction
11.6. Rapid Test
12. Pet Disease Diagnostic Reagent Market, by Test Type
12.1. Introduction
12.2. Antibody Test
12.3. Antigen Test
12.4. Biochemical Test
12.5. Molecular Test
12.5.1. Isothermal Amplification Test
12.5.2. NGS Test
12.5.3. PCR Test
12.5.4. qPCR Test
13. Americas Pet Disease Diagnostic Reagent Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Pet Disease Diagnostic Reagent Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Pet Disease Diagnostic Reagent Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. IDEXX Laboratories, Inc.
16.3.2. Zoetis Inc.
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. Merck & Co., Inc.
16.3.5. Heska Corporation
16.3.6. Bio-Rad Laboratories, Inc.
16.3.7. Neogen Corporation
16.3.8. Virbac SA
16.3.9. Vetoquinol SA
16.3.10. Biogal Galed Laboratories Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PET DISEASE DIAGNOSTIC REAGENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PET DISEASE DIAGNOSTIC REAGENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PET DISEASE DIAGNOSTIC REAGENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PET DISEASE DIAGNOSTIC REAGENT MARKET: RESEARCHAI
FIGURE 26. PET DISEASE DIAGNOSTIC REAGENT MARKET: RESEARCHSTATISTICS
FIGURE 27. PET DISEASE DIAGNOSTIC REAGENT MARKET: RESEARCHCONTACTS
FIGURE 28. PET DISEASE DIAGNOSTIC REAGENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PET DISEASE DIAGNOSTIC REAGENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY GENETIC DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY GENETIC DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY BACTERIAL INFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY BACTERIAL INFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY FUNGAL INFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY FUNGAL INFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY VIRAL INFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY VIRAL INFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY METABOLIC DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY METABOLIC DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ECTOPARASITIC INFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ECTOPARASITIC INFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY HELMINTH INFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY HELMINTH INFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PROTOZOAN INFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PROTOZOAN INFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY HOMECARE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY HOMECARE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY VETERINARY DIAGNOSTIC LAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY VETERINARY DIAGNOSTIC LAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY VETERINARY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY VETERINARY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY CAT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY CAT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DOG, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DOG, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY EQUINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY EQUINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY POULTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY RAPID TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY RAPID TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANTIBODY TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANTIBODY TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANTIGEN TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANTIGEN TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY BIOCHEMICAL TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY BIOCHEMICAL TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ISOTHERMAL AMPLIFICATION TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ISOTHERMAL AMPLIFICATION TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY NGS TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY NGS TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PCR TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PCR TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY QPCR TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY QPCR TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 127. CANADA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 128. CANADA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 129. CANADA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 130. CANADA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 131. CANADA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2018-2024 (USD MILLION)
TABLE 132. CANADA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2025-2030 (USD MILLION)
TABLE 133. CANADA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. CANADA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. CANADA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 136. CANADA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 137. CANADA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 138. CANADA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 139. CANADA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 140. CANADA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 141. CANADA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 142. CANADA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 143. MEXICO PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 144. MEXICO PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 145. MEXICO PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. MEXICO PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. MEXICO PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 152. MEXICO PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 153. MEXICO PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 154. MEXICO PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 155. MEXICO PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 156. MEXICO PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 157. MEXICO PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 158. MEXICO PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 225. GERMANY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 226. GERMANY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 227. GERMANY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 228. GERMANY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 229. GERMANY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2018-2024 (USD MILLION)
TABLE 230. GERMANY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2025-2030 (USD MILLION)
TABLE 231. GERMANY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. GERMANY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. GERMANY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 234. GERMANY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 235. GERMANY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 236. GERMANY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 237. GERMANY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 238. GERMANY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 239. GERMANY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 240. GERMANY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 241. FRANCE PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 242. FRANCE PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 243. FRANCE PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 244. FRANCE PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 245. FRANCE PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2018-2024 (USD MILLION)
TABLE 246. FRANCE PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2025-2030 (USD MILLION)
TABLE 247. FRANCE PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. FRANCE PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. FRANCE PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 250. FRANCE PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 251. FRANCE PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. FRANCE PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. FRANCE PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 254. FRANCE PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 255. FRANCE PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 256. FRANCE PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 273. ITALY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 274. ITALY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 275. ITALY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 276. ITALY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 277. ITALY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2018-2024 (USD MILLION)
TABLE 278. ITALY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2025-2030 (USD MILLION)
TABLE 279. ITALY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. ITALY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. ITALY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 282. ITALY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 283. ITALY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 284. ITALY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 285. ITALY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 286. ITALY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 287. ITALY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 288. ITALY PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 289. SPAIN PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
TABLE 290. SPAIN PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
TABLE 291. SPAIN PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 292. SPAIN PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 293. SPAIN PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2018-2024 (USD MILLION)
TABLE 294. SPAIN PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY PARASITIC DISEASE, 2025-2030 (USD MILLION)
TABLE 295. SPAIN PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. SPAIN PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SPAIN PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 298. SPAIN PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 299. SPAIN PET DISEASE DIAGNOSTIC REAGENT MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 300. SPAIN PET DISEASE DIAGNOSTIC REAGENT MARKET S

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Pet Disease Diagnostic Reagent market report include:
  • IDEXX Laboratories, Inc.
  • Zoetis Inc.
  • Thermo Fisher Scientific Inc.
  • Merck & Co., Inc.
  • Heska Corporation
  • Bio-Rad Laboratories, Inc.
  • Neogen Corporation
  • Virbac SA
  • Vetoquinol SA
  • Biogal Galed Laboratories Ltd.

Related Topics

Related Reports

Veterinary Molecular Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2025-2033 - Product Image

Veterinary Molecular Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2025-2033

  • Report
  • 137 Pages
  • Global
From
Veterinary Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2024-2032 - Product Image

Veterinary Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2024-2032

  • Report
  • 150 Pages
  • Global
From
Veterinary Infectious Disease Diagnostics Market by Disease Category (Bacterial, Fungal, Parasitic), Product (Consumables, Instruments/Analyzers), Offering, Animal Type, End Use - Global Forecast 2025-2030 - Product Image

Veterinary Infectious Disease Diagnostics Market by Disease Category (Bacterial, Fungal, Parasitic), Product (Consumables, Instruments/Analyzers), Offering, Animal Type, End Use - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Veterinary Molecular Diagnostics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 - Product Image

Veterinary Molecular Diagnostics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

  • Report
  • 150 Pages
  • Global
From
Companion Animal Diagnostics Market by Type Of Diagnostic Test (Hematology, Histopathology, Imaging), Product Type (Consumables, Instruments/Analyzers), Animal Type, End-User, Application - Global Forecast 2025-2030 - Product Image

Companion Animal Diagnostics Market by Type Of Diagnostic Test (Hematology, Histopathology, Imaging), Product Type (Consumables, Instruments/Analyzers), Animal Type, End-User, Application - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.